Neuland Laboratories

Neuland Laboratories EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Neuland Laboratories (NEULANDLAB.NS) as of Oct 18, 2026 is -269.42. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 141.63 — a change of -290.23% (lower).

EV/FCF

-269.42

YoY

-290.23%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Neuland Laboratories is 2026 -269.42 . EV/FCF (Enterprise Value to Free Cash Flow) of Neuland Laboratories was 2025 141.63 . It decreases by -290.23% lower compared to the previous year.

The Neuland Laboratories EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
2,372.06 INR
Jan 1, 2020
1,890.62 INR
Jan 1, 2021
191.63 INR
Jan 1, 2022
-433.03 INR
Jan 1, 2023
92.82 INR
Jan 1, 2024
142.05 INR
Jan 1, 2025
141.63 INR
Jan 1, 2026
-269.42 INR
The Neuland Laboratories EV/FCF history
YEAREV/FCFYoY
-269.42-290.23%
141.63-0.29%
142.05+53.04%
92.82-121.43%
-433.03-325.97%
191.63-89.86%
1,890.62-20.30%
2,372.06-1,888.19%
-132.65-97.98%
-6,581.09-1,144.33%
630.17-108.90%
-7,079.44-1,529.06%
495.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Neuland Laboratories Stock analysis

What does Neuland Laboratories do? Neuland Laboratories Ltd, headquartered in Hyderabad, India, operates in the Pharmaceuticals sector within the Health Care industry. The company manufactures and exports bulk pharmaceutical ingredients and intermediates for the generics industry, serving both domestic and international markets. With 1,573 employees, Neuland provides active pharmaceutical ingredients (APIs) and end-to-end chemistry solutions, including custom manufacturing services for generic drug substances and advanced intermediates across clinical and commercial stages. Its business is structured into two verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Neuland Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuland Laboratories stock

EV/FCF (Enterprise Value to Free Cash Flow) of Neuland Laboratories is -269.42 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Neuland Laboratories changed from 141.63 to -269.42, representing a -290.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Neuland Laboratories since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Neuland Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Neuland Laboratories

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Neuland Laboratories